Ataxia telangiectasia mutated in cardiac fibroblasts regulates doxorubicin-induced cardiotoxicity. Issue 1 (9th February 2016)
- Record Type:
- Journal Article
- Title:
- Ataxia telangiectasia mutated in cardiac fibroblasts regulates doxorubicin-induced cardiotoxicity. Issue 1 (9th February 2016)
- Main Title:
- Ataxia telangiectasia mutated in cardiac fibroblasts regulates doxorubicin-induced cardiotoxicity
- Authors:
- Zhan, Hong
Aizawa, Kenichi
Sun, Junqing
Tomida, Shota
Otsu, Kinya
Conway, Simon J.
Mckinnon, Peter J.
Manabe, Ichiro
Komuro, Issei
Miyagawa, Kiyoshi
Nagai, Ryozo
Suzuki, Toru - Abstract:
- Abstract: Aims: Doxorubicin (Dox) is a potent anticancer agent that is widely used in the treatment of a variety of cancers, but its usage is limited by cumulative dose-dependent cardiotoxicity mainly due to oxidative damage. Ataxia telangiectasia mutated (ATM) kinase is thought to play a role in mediating the actions of oxidative stress. Here, we show that ATM in cardiac fibroblasts is essential for Dox-induced cardiotoxicity. Methods and results: ATM knockout mice showed attenuated Dox-induced cardiotoxic effects (e.g. cardiac dysfunction, apoptosis, and mortality). As ATM was expressed and activated predominantly in cardiac fibroblasts, fibroblast-specific Atm -deleted mice ( Atm fl/fl ; Postn-Cre ) were generated to address cell type-specific effects, which showed that the fibroblast is the key lineage mediating Dox-induced cardiotoxicity through ATM. Mechanistically, ATM activated the Fas ligand, which subsequently regulated apoptosis in cardiomyocytes at later stages. Therapeutically, a potent and selective inhibitor of ATM, KU55933, when administered systemically was able to prevent Dox-induced cardiotoxicity. Conclusion: ATM-regulated effects within cardiac fibroblasts are pivotal in Dox-induced cardiotoxicity, and antagonism of ATM and its functions may have potential therapeutic implications.
- Is Part Of:
- Cardiovascular research. Volume 110:Issue 1(2016)
- Journal:
- Cardiovascular research
- Issue:
- Volume 110:Issue 1(2016)
- Issue Display:
- Volume 110, Issue 1 (2016)
- Year:
- 2016
- Volume:
- 110
- Issue:
- 1
- Issue Sort Value:
- 2016-0110-0001-0000
- Page Start:
- 85
- Page End:
- 95
- Publication Date:
- 2016-02-09
- Subjects:
- Doxorubicin -- Ataxia telangiectasia mutated -- Cardiac fibroblasts -- Doxorubicin-induced cardiotoxicity
Cardiovascular system -- Diseases -- Periodicals
Cardiovascular system -- Periodicals
616.1 - Journal URLs:
- http://cardiovascres.oxfordjournals.org ↗
http://ukcatalogue.oup.com/ ↗
http://www.sciencedirect.com/science/journal/00086363 ↗ - DOI:
- 10.1093/cvr/cvw032 ↗
- Languages:
- English
- ISSNs:
- 0008-6363
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3051.490000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25125.xml